Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.

Foschini MP, Miglio R, Fiore R, Baldovini C, Castellano I, Callagy G, Bianchi S, Kaya H, Amendoeira I, Querzoli P, Poli F, Scatena C, Cordoba A, Pietribiasi F, Kovács A, Faistova H, Cserni G, Quinn C.

Eur J Surg Oncol. 2019 Dec;45(12):2279-2286. doi: 10.1016/j.ejso.2019.07.011. Epub 2019 Jul 5.

PMID:
31301938
2.

Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer.

Demicheli R, Fornili M, Querzoli P, Pedriali M, Alberti S, Desmedt C, Biganzoli E.

Cancer Commun (Lond). 2019 Jun 19;39(1):35. doi: 10.1186/s40880-019-0381-9. No abstract available.

3.

HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.

Da Ros L, Moretti A, Querzoli P, Pedriali M, Lupini L, Bassi C, Carcoforo P, Negrini M, Frassoldati A.

Clin Breast Cancer. 2018 Oct;18(5):e1133-e1139. doi: 10.1016/j.clbc.2018.04.006. Epub 2018 Apr 18.

PMID:
29759595
4.

Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.

Lozada JR, Basili T, Pareja F, Alemar B, Paula ADC, Gularte-Merida R, Giri DD, Querzoli P, Cserni G, Rakha EA, Foschini MP, Reis-Filho JS, Brogi E, Weigelt B, Geyer FC.

Histopathology. 2018 Aug;73(2):339-344. doi: 10.1111/his.13522. Epub 2018 Jun 1.

5.

High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy.

Lupini L, Moretti A, Bassi C, Schirone A, Pedriali M, Querzoli P, Roncarati R, Frassoldati A, Negrini M.

Sci Rep. 2018 Mar 12;8(1):4371. doi: 10.1038/s41598-018-22312-x.

6.

An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.

Wesseling J, Tinterri C, Sapino A, Zanconati F, Lutke-Holzik M, Nguyen B, Deck KB, Querzoli P, Perin T, Giardina C, Seitz G, Guinebretière JM, Barone J, Dekker L, de Snoo F, Stork-Sloots L, Roepman P, Watanabe T, Cusumano P.

Virchows Arch. 2016 Sep;469(3):297-304. doi: 10.1007/s00428-016-1979-9. Epub 2016 Jul 4.

PMID:
27377889
7.

Lymph Node Micrometastases Do Influence Breast Cancer Outcome.

Antolini L, Biganzoli E, Querzoli P, Piantelli M, Alberti S.

J Clin Oncol. 2015 Nov 20;33(33):3977-8. doi: 10.1200/JCO.2015.63.0962. Epub 2015 Aug 17. No abstract available.

PMID:
26282637
8.

Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.

Mangolini A, Ferracin M, Zanzi MV, Saccenti E, Ebnaof SO, Poma VV, Sanz JM, Passaro A, Pedriali M, Frassoldati A, Querzoli P, Sabbioni S, Carcoforo P, Hollingsworth A, Negrini M.

Biomark Res. 2015 Jun 6;3:12. doi: 10.1186/s40364-015-0037-0. eCollection 2015.

9.

Serologic investigation of undifferentiated nasopharyngeal carcinoma and simian virus 40 infection.

Mazzoni E, Martini F, Corallini A, Taronna A, Barbanti-Brodano G, Querzoli P, Magri E, Rotondo JC, Dolcetti R, Vaccher E, Tognon M.

Head Neck. 2016 Feb;38(2):232-6. doi: 10.1002/hed.23879. Epub 2015 Jun 16.

PMID:
25244358
10.

Trop-2 is a determinant of breast cancer survival.

Ambrogi F, Fornili M, Boracchi P, Trerotola M, Relli V, Simeone P, La Sorda R, Lattanzio R, Querzoli P, Pedriali M, Piantelli M, Biganzoli E, Alberti S.

PLoS One. 2014 May 13;9(5):e96993. doi: 10.1371/journal.pone.0096993. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e110606.

11.

miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.

Ferracin M, Bassi C, Pedriali M, Pagotto S, D'Abundo L, Zagatti B, Corrà F, Musa G, Callegari E, Lupini L, Volpato S, Querzoli P, Negrini M.

Mol Cancer. 2013 Oct 28;12(1):130. doi: 10.1186/1476-4598-12-130.

12.

Breast cancer and simian virus 40 infection.

Martini F, Mazzoni E, Corallini A, Taronna A, Querzoli P, Magri E, Marci R, Dolcetti R, Rezza G, Barbanti-Brodano G, Tognon M.

Epidemiology. 2013 May;24(3):464-5. doi: 10.1097/EDE.0b013e31828d3ae6. No abstract available.

PMID:
23549184
13.

Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma).

Mantovani L, Zauli S, Sarno O, Querzoli P, Corazza M, Virgili A.

Int J Dermatol. 2013 Jun;52(6):753-6. doi: 10.1111/j.1365-4632.2012.05755.x. Epub 2013 Jan 20.

PMID:
23330662
14.

Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.

Alberti S, Ambrogi F, Boracchi P, Fornili M, Querzoli P, Pedriali M, La Sorda R, Lattanzio R, Tripaldi R, Piantelli M, Biganzoli E, Coradini D.

Jpn J Clin Oncol. 2012 Dec;42(12):1128-37. doi: 10.1093/jjco/hys159. Epub 2012 Oct 16.

PMID:
23072840
15.

Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation.

Aguiari G, Bizzarri F, Bonon A, Mangolini A, Magri E, Pedriali M, Querzoli P, Somlo S, Harris PC, Catizone L, Del Senno L.

J Mol Med (Berl). 2012 Nov;90(11):1267-82. doi: 10.1007/s00109-012-0902-3. Epub 2012 May 9.

16.

Metastatic syringoid eccrine carcinoma of the nipple.

Ballardini P, Margutti G, Pedriali M, Querzoli P.

Int Med Case Rep J. 2012 Jul 11;5:45-8. doi: 10.2147/IMCRJ.S32217. Print 2012.

17.

MicroRNAs: toward the clinic for breast cancer patients.

Ferracin M, Querzoli P, Calin GA, Negrini M.

Semin Oncol. 2011 Dec;38(6):764-75. doi: 10.1053/j.seminoncol.2011.08.005. Review.

PMID:
22082762
18.

MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.

Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G, Maestri I, Ulazzi L, Nenci I, Croce CM, Lanza G, Querzoli P, Negrini M.

J Pathol. 2011 Sep;225(1):43-53. doi: 10.1002/path.2915. Epub 2011 Jun 1.

19.

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

Campiglio M, Bufalino R, Sandri M, Ferri E, Aiello RA, De Matteis A, Mottolese M, De Placido S, Querzoli P, Jirillo A, Bottini A, Fantini M, Bonetti A, Pedani F, Mauri M, Molino A, Ferro A, Pupa SM, Sasso M, Ménard S, Balsari A, Tagliabue E.

Breast Cancer Res Treat. 2011 Jul;128(1):147-54. doi: 10.1007/s10549-011-1484-4. Epub 2011 Apr 11.

PMID:
21479926
20.

p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features.

Biganzoli E, Coradini D, Ambrogi F, Garibaldi JM, Lisboa P, Soria D, Green AR, Pedriali M, Piantelli M, Querzoli P, Demicheli R, Boracchi P, Nenci I, Ellis IO, Alberti S.

Jpn J Clin Oncol. 2011 Feb;41(2):172-9. doi: 10.1093/jjco/hyq227. Epub 2011 Jan 2.

PMID:
21199790
21.

An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer.

Querzoli P, Coradini D, Pedriali M, Boracchi P, Ambrogi F, Raimondi E, La Sorda R, Lattanzio R, Rinaldi R, Lunardi M, Frasson C, Modesti F, Ferretti S, Piantelli M, Iacobelli S, Biganzoli E, Nenci I, Alberti S.

Br J Cancer. 2010 Dec 7;103(12):1835-9. doi: 10.1038/sj.bjc.6605991. Epub 2010 Nov 9.

22.

Oncogenic role of miR-483-3p at the IGF2/483 locus.

Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F, Zanesi N, Alder H, D'Elia G, Gramantieri L, Bolondi L, Lanza G, Querzoli P, Angioni A, Croce CM, Negrini M.

Cancer Res. 2010 Apr 15;70(8):3140-9. doi: 10.1158/0008-5472.CAN-09-4456. Epub 2010 Apr 13.

23.

CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.

Miotto D, Lo Cascio N, Stendardo M, Querzoli P, Pedriali M, De Rosa E, Fabbri LM, Mapp CE, Boschetto P.

Lung Cancer. 2010 Sep;69(3):355-60. doi: 10.1016/j.lungcan.2009.12.012. Epub 2010 Jan 20.

PMID:
20089329
24.

High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies.

Tinari N, Lattanzio R, Querzoli P, Natoli C, Grassadonia A, Alberti S, Hubalek M, Reimer D, Nenci I, Bruzzi P, Piantelli M, Iacobelli S; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO).

Int J Cancer. 2009 Jan 15;124(2):333-8. doi: 10.1002/ijc.23970.

25.

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score.

Ménard S, Balsari A, Tagliabue E, Camerini T, Casalini P, Bufalino R, Castiglioni F, Carcangiu ML, Gloghini A, Scalone S, Querzoli P, Lunardi M, Molino A, Mandarà M, Mottolese M, Marandino F, Venturini M, Bighin C, Cancello G, Montagna E, Perrone F, De Matteis A, Sapino A, Donadio M, Battelli N, Santinelli A, Pavesi L, Lanza A, Zito FA, Labriola A, Aiello RA, Caruso M, Zanconati F, Mustacchi G, Barbareschi M, Frisinghelli M, Russo R, Carrillo G; OMERO Group.

Ann Oncol. 2008 Oct;19(10):1706-12. doi: 10.1093/annonc/mdn369. Epub 2008 Jun 9.

26.

Sex hormone receptor levels in laryngeal carcinoma: a comparison between protein and RNA evaluations.

Bianchini C, Pastore A, Pelucchi S, Torreggiani E, Lambertini E, Marchesi E, Magri E, Frasson C, Querzoli P, Piva R.

Eur Arch Otorhinolaryngol. 2008 Sep;265(9):1089-94. doi: 10.1007/s00405-008-0589-9. Epub 2008 Feb 2.

PMID:
18246362
27.

Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer.

Boschetto P, Zeni E, Mazzetti L, Miotto D, Lo Cascio N, Maestrelli P, Marian E, Querzoli P, Pedriali M, Murer B, De Rosa E, Fabbri LM, Mapp CE.

Lung Cancer. 2008 Feb;59(2):192-7. Epub 2007 Sep 27.

PMID:
17900753
28.

Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer.

Zeni E, Mazzetti L, Miotto D, Lo Cascio N, Maestrelli P, Querzoli P, Pedriali M, De Rosa E, Fabbri LM, Mapp CE, Boschetto P.

Eur Respir J. 2007 Oct;30(4):627-32. Epub 2007 May 30.

29.

Increased neurokinin-2 receptor expression in alveolar macrophages of smokers with COPD.

Miotto D, Boschetto P, Cavallesco G, Zeni E, Querzoli P, Pedriali M, Chiarelli S, Fabbri LM, Mapp CE.

Histopathology. 2007 Jul;51(1):128-31. Epub 2007 May 26. No abstract available.

PMID:
17532769
30.

Phospholipase C-beta 2 promotes mitosis and migration of human breast cancer-derived cells.

Bertagnolo V, Benedusi M, Brugnoli F, Lanuti P, Marchisio M, Querzoli P, Capitani S.

Carcinogenesis. 2007 Aug;28(8):1638-45. Epub 2007 Apr 11.

PMID:
17429106
31.

Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients.

Querzoli P, Pedriali M, Rinaldi R, Lombardi AR, Biganzoli E, Boracchi P, Ferretti S, Frasson C, Zanella C, Ghisellini S, Ambrogi F, Antolini L, Piantelli M, Iacobelli S, Marubini E, Alberti S, Nenci I.

Clin Cancer Res. 2006 Nov 15;12(22):6696-701.

32.

Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up.

Carcoforo P, Sortini D, Feggi L, Feo CV, Soliani G, Panareo S, Corcione S, Querzoli P, Maravegias K, Lanzara S, Liboni A.

Ann Surg Oncol. 2006 Oct;13(10):1338-43. Epub 2006 Sep 3.

PMID:
16952022
33.

Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases.

Carcoforo P, Maestroni U, Querzoli P, Lanzara S, Maravegias K, Feggi L, Soliani G, Basaglia E.

World J Surg. 2006 Sep;30(9):1653-7.

PMID:
16927059
34.

PLC-beta2 is highly expressed in breast cancer and is associated with a poor outcome: a study on tissue microarrays.

Bertagnolo V, Benedusi M, Querzoli P, Pedriali M, Magri E, Brugnoli F, Capitani S.

Int J Oncol. 2006 Apr;28(4):863-72.

PMID:
16525635
35.

Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods.

Ambrogi F, Biganzoli E, Querzoli P, Ferretti S, Boracchi P, Alberti S, Marubini E, Nenci I.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):781-90.

36.

MicroRNA gene expression deregulation in human breast cancer.

Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM.

Cancer Res. 2005 Aug 15;65(16):7065-70.

37.

Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT).

Paradiso A, Volpe S, Iacobacci A, Marubini E, Verderio P, Costa A, Daidone MG, Marchetti A, Mottolese M, Amadori D, De Paola F, Saragoni L, Medri L, Nenci I, Querzoli P, Gion M, Dittadi R, Plebani M, Orlando C, Bevilacqua G, Silvestrini R; Italian Network for Quality Assessment of Tumor Biomarkers.

Int J Biol Markers. 2002 Jul-Sep;17(3):201-14.

PMID:
12408472
38.

Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer.

Carcoforo P, Bergossi L, Basaglia E, Soliani G, Querzoli P, Zambrini E, Pozza E, Feggi L.

Tumori. 2002 May-Jun;88(3):S4-5.

PMID:
12365385
39.

Loss of methylation at chromosome 11p15.5 is common in human adult tumors.

Scelfo RA, Schwienbacher C, Veronese A, Gramantieri L, Bolondi L, Querzoli P, Nenci I, Calin GA, Angioni A, Barbanti-Brodano G, Negrini M.

Oncogene. 2002 Apr 11;21(16):2564-72.

40.

An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.

Feggi L, Basaglia E, Corcione S, Querzoli P, Soliani G, Ascanelli S, Prandini N, Bergossi L, Carcoforo P.

Eur J Nucl Med. 2001 Nov;28(11):1589-96.

PMID:
11702098
41.

Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.

Querzoli P, Albonico G, di Iasio MG, Ferretti S, Rinaldi R, Cariello A, Pedriali M, Matteuzzi M, Maestri I, Nenci I.

Breast Cancer Res Treat. 2001 Mar;66(2):135-42.

PMID:
11437099
42.

Human herpesvirus 7 is latent in gastric mucosa.

Gonelli A, Boccia S, Boni M, Pozzoli A, Rizzo C, Querzoli P, Cassai E, Di Luca D.

J Med Virol. 2001 Apr;63(4):277-83.

PMID:
11241458
43.

Sentinel node study in early breast cancer.

Feggi LM, Querzoli P, Prandini N, Corcione S, Bergossi L, Basaglia E, Carcoforo P.

Tumori. 2000 Jul-Aug;86(4):314-6.

PMID:
11016713
44.

Quantitative immunoprofiles of breast cancer performed by image analysis.

Querzoli P, Albonico G, Ferretti S, Rinaldi R, Magri E, Nenci I.

Anal Quant Cytol Histol. 1999 Apr;21(2):151-60.

PMID:
10560485
45.

Biological profile of in situ breast cancer investigated by immunohistochemical technique.

Albonico G, Querzoli P, Ferretti S, Rinaldi R, Nenci I.

Cancer Detect Prev. 1998;22(4):313-8.

PMID:
9674874
46.

Modulation of biomarkers in minimal breast carcinoma: a model for human breast carcinoma progression.

Querzoli P, Albonico G, Ferretti S, Rinaldi R, Beccati D, Corcione S, Indelli M, Nenci I.

Cancer. 1998 Jul 1;83(1):89-97.

PMID:
9655297
47.

90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells.

Fusco O, Querzoli P, Nenci I, Natoli C, Brakebush C, Ullrich A, Iacobelli S.

Int J Cancer. 1998 Feb 20;79(1):23-6.

48.

MIB-1 proliferative activity in invasive breast cancer measured by image analysis.

Querzoli P, Albonico G, Ferretti S, Rinaldi R, Magri E, Indelli M, Nenci I.

J Clin Pathol. 1996 Nov;49(11):926-30.

49.

Biological heterogeneity of breast carcinoma in situ.

Albonico G, Querzoli P, Ferretti S, Rinaldi R, Nenci I.

Ann N Y Acad Sci. 1996 Apr 30;784:458-61. No abstract available.

PMID:
8651598
50.

Biological staging of incipient, in situ, and invasive breast carcinomas.

Querzoli P, Albonico G, Ferretti S, Rinaldi R, Nenci I.

Ann N Y Acad Sci. 1996 Apr 30;784:381-94. No abstract available.

PMID:
8651586

Supplemental Content

Loading ...
Support Center